한국어
English
日本語
中文(简体)
Zelcor Capsule 200 mg (Crizotinib)
200mg
Hard capsule · Prescription medication
Pfizer Pharmaceuticals Korea Co., Ltd.
Crizotinib is an anticancer active ingredient that inhibits the growth of specific cancer cells.
MFDS ingredient code M253698
Crizotinib is an anticancer drug that belongs to the targeted therapy category and is primarily used for the treatment of cancers with specific genetic mutations, such as non-small cell lung cancer. This ingredient works by blocking the activity of certain proteins that promote the growth and proliferation of cancer cells.
Crizotinib inhibits the activity of specific proteins, ALK and ROS1, within cancer cells, disrupting the process by which cancer cells grow and divide. This helps to slow down or stop the proliferation of cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Crizotinib is a targeted therapy specialized for cancers with ALK and ROS1 genetic mutations, which aims to reduce side effects and enhance therapeutic efficacy by targeting specific molecular mechanisms, unlike traditional chemotherapeutic agents.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
